Abbvie Endocrine Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBVIE ENDOCRINE, and what generic alternatives to ABBVIE ENDOCRINE drugs are available?
ABBVIE ENDOCRINE has seven approved drugs.
There are two US patents protecting ABBVIE ENDOCRINE drugs.
There are thirty-five patent family members on ABBVIE ENDOCRINE drugs in twenty-eight countries.
Summary for Abbvie Endocrine
International Patents: | 35 |
US Patents: | 2 |
Tradenames: | 4 |
Ingredients: | 2 |
NDAs: | 7 |
Drugs and US Patents for Abbvie Endocrine
Expired US Patents for Abbvie Endocrine
International Patents for Abbvie Endocrine Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Colombia | 6180498 | ⤷ Try a Trial |
Ukraine | 97125 | ⤷ Try a Trial |
Malaysia | 148370 | ⤷ Try a Trial |
Japan | 2010513225 | ⤷ Try a Trial |
Norway | 20092662 | ⤷ Try a Trial |
Japan | 2010222371 | ⤷ Try a Trial |
Japan | 4564098 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.